These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32547950)

  • 21. The Chile Biliary Longitudinal Study: A Gallstone Cohort.
    Koshiol J; Van De Wyngard V; McGee EE; Cook P; Pfeiffer RM; Mardones N; Medina K; Olivo V; Pettit K; Jackson SS; Paredes F; Sanchez R; Huidobro A; Villaseca M; Bellolio E; Losada H; Roa JC; Hildesheim A; Araya JC; Ferreccio C;
    Am J Epidemiol; 2021 Feb; 190(2):196-206. PubMed ID: 33524121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
    Niu J; Li Z; Li F
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bmi-1 in gallbladder carcinoma: Clinicopathology and mechanism of regulation of human gallbladder carcinoma proliferation.
    Jiao K; Jiang W; Zhao C; Su D; Zhang H
    Oncol Lett; 2019 Aug; 18(2):1365-1371. PubMed ID: 31423199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway.
    Shen S; Liu H; Wang Y; Wang J; Ni X; Ai Z; Pan H; Liu H; Shao Y
    Oncotarget; 2016 Nov; 7(45):72833-72844. PubMed ID: 27637083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway.
    Yang L; Gao Q; Wu X; Feng F; Xu K
    J Exp Clin Cancer Res; 2018 Aug; 37(1):186. PubMed ID: 30086773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies.
    Koshiol J; Castro F; Kemp TJ; Gao YT; Roa JC; Wang B; Nogueira L; Araya JC; Shen MC; Rashid A; Hsing AW; Hildesheim A; Ferreccio C; Pfeiffer RM; Pinto LA
    Cytokine; 2016 Jul; 83():217-225. PubMed ID: 27173614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological Study of Gallbladder Cancer Patients from North Indian Gangetic Planes--a High-Volume Centre's Experience.
    Gupta S; Kori C; Kumar V; Misra S; Akhtar N
    J Gastrointest Cancer; 2016 Mar; 47(1):27-35. PubMed ID: 26585944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of clinical outcomes of incidental and non- incidental gallbladder cancers: a single-center cross- sectional study.
    Cha BH; Bae JM
    Asian Pac J Cancer Prev; 2014; 15(3):1281-3. PubMed ID: 24606453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.
    Mohri D; Ijichi H; Miyabayashi K; Takahashi R; Kudo Y; Sasaki T; Asaoka Y; Tanaka Y; Ikenoue T; Tateishi K; Tada M; Isayama H; Koike K
    J Gastroenterol; 2016 Jul; 51(7):711-21. PubMed ID: 26614007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for gallbladder cancer: a case-control study.
    Jain K; Sreenivas V; Velpandian T; Kapil U; Garg PK
    Int J Cancer; 2013 Apr; 132(7):1660-6. PubMed ID: 22890893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions.
    Koshiol J; Gao YT; Corbel A; Kemp TJ; Shen MC; Hildesheim A; Hsing AW; Rashid A; Wang B; Pfeiffer RM; Pinto LA
    Cancer Epidemiol; 2018 Jun; 54():25-30. PubMed ID: 29554539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement receptor 1 (A3650G RsaI and intron 27 HindIII) polymorphisms and risk of gallbladder cancer in north Indian population.
    Srivastava A; Mittal B
    Scand J Immunol; 2009 Dec; 70(6):614-20. PubMed ID: 19906204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing the incidentally detected gallbladder cancer: algorithms and controversies.
    Cavallaro A; Piccolo G; Di Vita M; Zanghì A; Cardì F; Di Mattia P; Barbera G; Borzì L; Panebianco V; Di Carlo I; Cavallaro M; Cappellani A
    Int J Surg; 2014; 12 Suppl 2():S108-S119. PubMed ID: 25182380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.
    Wang S; Zhang Y; Cai Q; Ma M; Jin LY; Weng M; Zhou D; Tang Z; Wang JD; Quan Z
    Mol Cancer; 2019 Oct; 18(1):145. PubMed ID: 31623628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma.
    Hu YP; Wu ZB; Jiang L; Jin YP; Li HF; Zhang YJ; Ma Q; Ye YY; Wang Z; Liu YC; Chen HZ; Liu YB
    Int J Biochem Cell Biol; 2018 Apr; 97():16-27. PubMed ID: 29413947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
    Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
    Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer.
    Cao Y; Liu X; Lu W; Chen Y; Wu X; Li M; Wang XA; Zhang F; Jiang L; Zhang Y; Hu Y; Xiang S; Shu Y; Bao R; Li H; Wu W; Weng H; Yen Y; Liu Y
    Cancer Lett; 2015 May; 360(2):141-50. PubMed ID: 25657110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
    Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma.
    Moreno M; Pimentel F; Gazdar AF; Wistuba II; Miquel JF
    Ann Hepatol; 2005; 4(3):192-9. PubMed ID: 16177659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ursolic acid isolated from
    Chen H; Wu X; Duan Y; Zhi D; Zou M; Zhao Z; Zhang X; Yang X; Zhang J
    Oncol Lett; 2019 Aug; 18(2):1467-1474. PubMed ID: 31423212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.